首页> 美国卫生研究院文献>The Journal of Bone and Joint Surgery. American Volume >Higher Opioid Doses Predict Poorer Functional Outcome in Patients with Chronic Disabling Occupational Musculoskeletal Disorders
【2h】

Higher Opioid Doses Predict Poorer Functional Outcome in Patients with Chronic Disabling Occupational Musculoskeletal Disorders

机译:阿片类药物的剂量较高可预测慢性致残性职业性肌肉骨骼疾病患者的功能结局较差

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Background: Opioids are frequently used for the postoperative treatment of chronic disabling occupational musculoskeletal disorders. In many such cases, long-term opioid use persists because of patient requests for ongoing pain relief. Little is known about the relationship between chronic opioid use and functional recovery in these patients.>Methods: A total of 1226 patients with a chronic disabling occupational musculoskeletal disorder were consecutively admitted into an interdisciplinary functional restoration program. They were divided into two groups: 630 patients who reported no opioid use at the time of admission (No group) and 596 patients who reported some opioid use at the time of admission (Yes group). The 516 patients for whom daily opioid doses could be determined were further divided into four subgroups: Low (<30 mg, n = 267), Medium (31 to 60 mg, n = 112), High (61 to 120 mg, n = 78), and Very High (>120 mg, n = 59). During the initial weeks of treatment, patients consented to be weaned from all opioid medications. In addition, the patients were assessed before and after rehabilitation with regard to self-reported measures of pain, function, and depression and were analyzed for change. One year after the termination of treatment, socioeconomic outcomes were assessed to measure work and financial status, healthcare utilization, and recurrent injury-associated pain.>Results: A higher post-injury opioid dose was associated with a greater risk of program noncompletion, which was anticipated because of the requirement that patients taper opioids. High opioid use was significantly related to important socioeconomic outcomes, such as lower rates of return to work and work retention as well as higher healthcare utilization (p ≤ 0.05 for all). Moreover, at one year after treatment, the group reporting the highest opioid use was 11.6 times as likely to be receiving Social Security Disability Income/Supplemental Security Income as compared with the group reporting no opioid use at the time of admission into the program.>Conclusions: Chronic opioid use beginning after a work-related injury is a predictor of less successful outcomes for patients whose final treatment intervention is an interdisciplinary functional restoration program. Higher dose levels are associated with progressively greater indemnity and medical costs for ongoing disability. Physicians involved in the treatment of chronic disabling occupational musculoskeletal disorders should be aware of problems associated with permitting long-term opioid use in patients with a disabling occupational disorder.>Level of Evidence: Prognostic Level I. See Instructions to Authors for a complete description of levels of evidence.
机译:>背景:阿片类药物常用于慢性致残性职业性肌肉骨骼疾病的术后治疗。在许多此类情况下,由于患者要求持续缓解疼痛,长期使用阿片类药物仍然存在。对这些患者的慢性阿片类药物使用与功能恢复之间的关系知之甚少。>方法:总共有1226例患有慢性致残性职业性肌肉骨骼疾病的患者被连续纳入跨学科功能恢复计划。他们分为两组:630例入院时未使用阿片类药物的患者(无组)和596例入院时未使用阿片类药物的患者(是组)。可以确定每日阿片类药物剂量的516例患者进一步分为四个亚组:低(<30 mg,n = 267),中(31至60 mg,n = 112),高(61至120 mg,n = 78)和非常高(> 120 mg,n = 59)。在治疗的最初几周,患者同意从所有阿片类药物中断奶。另外,在康复前后对患者进行了自我报告的疼痛,功能和抑郁测量,并对患者的变化进行了分析。治疗终止后一年,评估了社会经济结果以衡量工作和财务状况,医疗保健利用率以及与损伤相关的复发性疼痛。>结果:阿片类药物损伤后剂量越高与阿片类药物剂量越大有关。程序未完成的风险,这是可以预料的,因为要求患者逐渐减少阿片类药物的使用。大量使用阿片类药物与重要的社会经济成果显着相关,例如较低的工作回报率和工作保留率以及较高的医疗保健利用率(所有p≤0.05)。此外,治疗后一年,报告使用阿片类药物最高的小组获得社会保障残疾收入/补充保障收入的可能性是入院时未报告使用阿片类药物的小组的11.6倍。 strong>结论:与工作相关的损伤后开始长期使用阿片类药物预示着最终治疗干预为跨学科功能恢复计划的患者预后较差。较高的剂量水平会导致持续残疾的赔偿和医疗费用逐渐增加。参与治疗慢性致残性职业性肌肉骨骼疾病的医师应意识到与致残性职业性疾病患者长期使用阿片类药物有关的问题。>证据级别:预后级别I。请参阅作者对证据水平的完整描述。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号